Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Sleep Number Corporation. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sleep Number Corporation (“Sleep Number” or “the Company”) (NASDAQ: SNBR). Investors who purchased Sleep Number securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Sleep Number has violated federal securities laws.
Sleep Number Investigation Details
On May 12, 2026, Sleep Number released its Q1 2026 financial results. The Company’s earnings per share fell far short of consensus estimates, representing a 18.9% year-over-year decline. The Company also suspended its financial guidance. Following this news, Sleep Number’s stock price fell 22.45% that same day.
What’s Next for Sleep Number Investors?
If you are aware of any facts relating to this investigation or purchased Sleep Number securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
SNBR — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”